Level Biotechnology Inc. (TPEX:3118)
33.45
-0.05 (-0.15%)
Mar 4, 2026, 1:28 PM CST
Level Biotechnology Revenue
In the year 2025, Level Biotechnology had annual revenue of 736.59M TWD with 0.72% growth. Level Biotechnology had revenue of 188.03M in the quarter ending December 31, 2025, a decrease of -8.16%.
Revenue
736.59M
Revenue Growth
+0.72%
P/S Ratio
1.47
Revenue / Employee
5.58M
Employees
132
Market Cap
1.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 736.59M | 5.25M | 0.72% |
| Dec 31, 2024 | 731.35M | 70.74M | 10.71% |
| Dec 31, 2023 | 660.61M | 67.60M | 11.40% |
| Dec 31, 2022 | 593.01M | -84.27M | -12.44% |
| Dec 31, 2021 | 677.28M | 4.79M | 0.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Meribank Biotech | 486.52M |
| Taiwan Advance Bio-Pharmaceutical | 371.86M |
| TCI GENE | 324.73M |
| GeneReach Biotechnology | 215.32M |
| NeoCore Technology | 190.10M |
| Lukas Biomedical | 180.32M |
| NatureWise Biotech & Medicals | 180.29M |
| Holy Stone Healthcare | 47.51M |